Bringing Cure...Building Hope...
Home | Blog | FAQs

Oncology Drugs Approved For
Multiple Myeloma by US FDA

IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import.

List of Drugs Approved for Multiple Myeloma Treatment

Multiple myeloma is a cancer that forms in a type of white blood cell called a plasma cell. Healthy plasma cells help you fight infections by making antibodies that recognize and attack germs. In multiple myeloma, cancerous plasma cells accumulate in the bone marrow and crowd out healthy blood cells. Treatment depends on stage:- Treatments include medication, chemotherapy, corticosteroids, radiation or a stem-cell transplant.

The following lists anti-cancer drugs, US FDA and Indian Generic brand approved by the Food and Drug Administration (FDA) for Multiple Myeloma treatment. The list includes generic and brand names are in some way related to, or used in the treatment of this condition. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

ALKERAN

ALKERAN ® (melphalan hydrochloride) for Injection Initial U.S. Approval: 2001

More Details...
BRAFTOVI

BRAFTOVI ™ (encorafenib) capsules, for oral use. Initial U.S. Approval: 2018.

More Details...
CALQUENCE

CALQUENCE ® (acalabrutinib) capsules, for oral use Initial U.S. Approval: 2017

More Details...
FARYDAK

FARYDAK ® (panobinostat) capsules, for oral use. Initial U.S. Approval: 2015

More Details...
MEKTOVI

MEKTOVI ® (binimetinib) tablets, for oral use. Initial U.S. Approval: 2018

More Details...
MYLOTARG

MYLOTARG (gemtuzumab ozogamicin) for injection, for intravenous use. Initial U.S. Approval: 2000

More Details...
NINLARO

NINLARO ® (ixazomib) capsules, for oral use Initial U.S. Approval: 2015

More Details...
XPOVIO

XPOVIO ™ (selinexor) tablets, for oral use Initial U.S. Approval: 2019

More Details...
SARCLISA

SARCLISA ® (isatuximab-irfc) injection, for intravenous use Initial U.S. Approval: 2020

More Details...
Note:-

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

CONTACT DETAILS
IPN, New Delhi India
Mobile: +91-9891296838 / 9811747774
WhatsApp: +91-9891296838
Email: info@indianpharmanetwork.co.in
Social Media:

Indian Pharma Network is registered medical pharmacy for Oncology Products in India.Helps you to access FDA approved Multiple Myeloma medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Multiple Myeloma Medicines in China, UAE, Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

If you have a question relating to anti-cancer medicines approved for treatment of Multiple Myeloma, a problem which you do not know how to resolve it, or concrete inquiry - we are here for you. We will answer you via email urgent@indianpharmanetwork.co.in as soon as possible. If you prefer to be contacted by phone, please leave your phone number. Or text your message in WhatsApp Number +91 9891296838 / 9811747774.

Indian Pharma Network, New Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur

US FDA Approved Oncology Drugs

For Lymphoma

The list includes US FDA approved brand drugs names are in some way related to, or used in the treatment of this condition.

IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India.

US FDA Approved Oncology Drugs

For Leukemia

The list includes US FDA approved brand drugs names are in some way related to, or used in the treatment of this condition.

IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India.

Indian FDA Approved Oncology Drugs

For Melanoma

The list includes FDA approved brand drugs names are in some way related to, or used in the treatment of this condition.

IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India.